Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Asset Utilization Ratio (2016 - 2022)

Historic Asset Utilization Ratio for Aptevo Therapeutics (APVO) over the last 7 years, with Q4 2022 value amounting to 0.09.

  • Aptevo Therapeutics' Asset Utilization Ratio fell 5364.32% to 0.09 in Q4 2022 from the same period last year, while for Dec 2022 it was 0.09, marking a year-over-year decrease of 5364.32%. This contributed to the annual value of 0.07 for FY2022, which is 6927.37% down from last year.
  • Latest data reveals that Aptevo Therapeutics reported Asset Utilization Ratio of 0.09 as of Q4 2022, which was down 5364.32% from 0.19 recorded in Q3 2022.
  • Over the past 5 years, Aptevo Therapeutics' Asset Utilization Ratio peaked at 0.85 during Q2 2020, and registered a low of 0.09 during Q4 2022.
  • For the 5-year period, Aptevo Therapeutics' Asset Utilization Ratio averaged around 0.28, with its median value being 0.22 (2018).
  • As far as peak fluctuations go, Aptevo Therapeutics' Asset Utilization Ratio soared by 20779.27% in 2020, and later tumbled by 8421.47% in 2021.
  • Quarter analysis of 5 years shows Aptevo Therapeutics' Asset Utilization Ratio stood at 0.23 in 2018, then skyrocketed by 149.15% to 0.57 in 2019, then crashed by 83.35% to 0.09 in 2020, then skyrocketed by 115.16% to 0.2 in 2021, then tumbled by 53.64% to 0.09 in 2022.
  • Its last three reported values are 0.09 in Q4 2022, 0.19 for Q3 2022, and 0.24 during Q2 2022.